Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.
An early trial suggests a combination of psilocybin and psychotherapy may be safe and effective for treatment-resistant depression associated with bipolar II disorder and deserves further study.
Patients with transthyretin amyloid cardiomyopathy taking tafamidis have less worsening of cardiac function than those on placebo, post hoc analysis of randomized results suggests.
Migraine is often thought of as a female disorder, but multiple factors make it difficult to determine its true prevalence in women and men.
A recent Swiss study, despite having a better methodology than previous research, can do little more than fuel hypotheses.